Article
Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis.
Experimental hematology - 1 Sept 1999
Josefsen D, Myklebust J H, Lynch D H, Stokke T, Blomhoff H K, Smeland E B
Abstract excerpt
Fas (CD95, APO-1) is a member of the TNF receptor family, and engagement of Fas by its ligand, Fas ligand (FasL), can induce apoptotic death of Fas expressing cells. Signaling through Fas has previously been shown to induce apoptosis of CD34+ human hematopoietic progenitor cells after exposure to IFN-gamma or TFN-alpha. In contrast, we found that FasL promoted a significantly increased viability of primitive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
